MVEIX
Price
$12.85
Change
-$0.02 (-0.16%)
Updated
Jul 13 closing price
Net Assets
20.1M
VMVAX
Price
$104.78
Change
+$0.48 (+0.46%)
Updated
Jul 13 closing price
Net Assets
37.23B
Interact to see
Advertisement

MVEIX vs VMVAX

MVEIX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
MVEIX vs. VMVAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVEIX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 37.2B vs. MVEIX (20.1M). VMVAX pays higher dividends than MVEIX: VMVAX (1.88) vs MVEIX (0.71). MVEIX was incepted earlier than VMVAX: MVEIX (28 years) vs VMVAX (15 years). MVEIX (1.48) is less costly to investors than VMVAX (0.07). MVEIX is a more actively managed with annual turnover of: 54.00 vs. VMVAX (23.00). VMVAX has a lower initial minimum investment than MVEIX: VMVAX (3000) vs MVEIX (10000). VMVAX annual gain was more profitable for investors over the last year : 20.58 vs. MVEIX (17.18). VMVAX return over 5 years is better than : 46.00 vs. MVEIX (8.64).
MVEIXVMVAXMVEIX / VMVAX
Total Expense Ratio1.480.072,114%
Annual Report Gross Expense Ratio1.480.072,114%
Fund Existence28 years15 years-
Gain YTD12.93913.61595%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets20.1M37.2B0%
Annual Yield % from dividends0.711.8838%
Returns for 1 year17.1820.5883%
Returns for 3 years31.2943.5672%
Returns for 5 years8.6446.0019%
Returns for 10 years18.26123.4115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCDAX49.03N/A
N/A
Fidelity Advisor Stock Selector Sm Cp A
SRIGX14.28N/A
N/A
Gabelli SRI AAA
EIVFX15.10N/A
N/A
Allspring Special Large Cap Value R6
EPDIX14.37N/A
N/A
EuroPac International Dividend Income I
DSMFX17.15N/A
N/A
Destinations Small-Mid Cap Equity I